# NIH Reporter #2R44GM154585-02

Development and Validation of Data Standards and Computational Methods for Large Scale Metabolomics Data Analysis for Data Driven Drug Discovery

**Recipient:** SINOPIA BIOSCIENCES, INC.

**Award Amount:** $1,477,110.00
**Ceiling:** $1,477,110.00

**Awarded:** September 10, 2026

**Identifier:** 2R44GM154585-02

The award supports the development of a scalable metabolomics platform to facilitate data-driven drug discovery, particularly for rare diseases, through data standardization, model validation, and preclinical testing.

### Description

This project focuses on developing a metabolomics-based platform (metD4) to improve drug discovery by profiling small molecules and identifying drug targets, especially for rare diseases like Familial Adenomatous Polyposis (FAP) and Gaucher Disease (GD). The platform aims to standardize metabolomics data comparison, enhance model performance, and translate findings into preclinical models.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11316610)